About Event
The Ultimate Meeting Point for the Cell & Gene Therapy Supply Chain & Clinical Delivery Community
As the established go-to industry meeting dedicated to securing the end-to-end cell and gene therapy supply chain, the 4th Supply Chain & Logistics Summit returned as the most comprehensive supply chain summit to date, with a BRAND NEW Clinical Delivery Track to synergize efforts between Supply Chain and Clinical Operations to deliver better therapies to patients, faster.
The 2023 meeting brought together over 120 supply chain experts across 3 days, 1 Standardization Focus Day, 2 tracks dedicated to Supply and Clinical Delivery, and 8 interactive panel sessions. This was a premier opportunity to network and brainstorm with fellow industry leaders in your Cell and Gene Therapy community to gain an unrivalled education and actionable takeaways in the execution of cost-effective, resilient and patient-centric supply chains.
Experts Joined to:
Integrate supply-clinical-vendor strategies to define and implement standards to improve visibility throughout the supply chain with ICCBBA, Roche and Johnson & Johnson
Build the technological infrastructure and functional data ecosystem to fast-track digitalization to enable commercial readiness with Roche, Vertex Pharmaceuticals and Precision Biosciences
Deploy effective scheduling, recruitment and patient management strategies to allocate resources efficiently to develop patient-centric supply chains with Novartis, Autolus, and Moffitt Cancer Centre
Navigate global quality compliance requirements to prevent unexpected barriers to enable phase-appropriate expansion with Intil Bio, AstraZeneca and Mustang Bio
Network face-to-face with supply chain professionals and discuss the most relevant challenges to gain actionable insights to build solutions with the end-patient in mind
Download the Full Event Guide to see the full scope of content and speakers.
Hear What Our Previous Attendees Have to Say:
‘The Supply Chain and Logistics for Cell Therapies Summit consistently delivers relevance for the sector with a shared sense of purpose and learning from an engaged faculty and audience’
William Shingler
Senior Director, Patient & Cell Management, Autolus
''It was great to connect with a like-minded and engaged community all trying to bring great therapies to patients’’
Tour Ala
Information Technology Leading for Cell & Gene Therapy Industrialization, Manufacturing & Supply Chain Professional, Roche
‘‘Great visibility to the challenges we are all facing and an opportunity to see how different companies are tackling them’’
Cindy McNab, Associate Director, External Manufacturing, Supply Chain, Allogene Therapeutics
“This meeting provides an opportunity to collaborate with colleagues on supply chain topics that are unique to immunotherapies, in the interest of consistently delivering the highest quality products to our patients”
Kirstin Powel, Global Head, External Quality Operations, Novartis Cell